Clinical trial · Interventional
FLT-PET Imaging of Brain Tumors in Children
Phase 2 Study of [18F]FLT for PET Imaging of Brain Tumors in Children
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Brain tumors are the leading cause of death from solid tumors in children. Tumor imaging is important in the management of these tumors, but current imaging methods have limitations in providing the necessary information for optimal treatment of these patients. The goal of this study is to evaluate the potential utility of positron emission tomography (PET) with 3'-deoxy-3'-\[F-18\] fluorothymidine (18F-FLT) in the medical management of brain tumors in children. Funding source - FDA Office of Orphan Product Development (OOPD)
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Brain Neoplasms | Brain Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| [18F] FLT | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- EXPERIMENTAL
- label
- New diagnosis of brain tumor
- description
- In children with a new diagnosis of central nervous system tumor, a PET scan will be performed using \[18F\] FLT.
- interventionNames
- Drug: [18F] FLT
- type
- EXPERIMENTAL
- label
- Possible recurrent brain tumor
- description
- In children in whom there is concern for recurrent central nervous system tumor, a PET scan will be performed using \[18F\] PET.
- interventionNames
- Drug: [18F] FLT
- type
- EXPERIMENTAL
- label
- Brain tumor response to chemotherapy
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Maximum age
- 21 Years
Show eligibility criteria text
Inclusion Criteria: * age 21 years or less * capable of achieving imaging without need for sedation or anesthesia (typically age 8 years or greater, but there is no lower limit for age for eligibility) * Karnofsky Performance Status of 50 or greater in subjects age 12 years or greater, for age less than 12 years a Lansky play scale of 50% or greater * Patients receiving steroids and/or anti-seizure medications are eligible Exclusion Criteria: * clinically active infection * pregnancy or breast-feeding * serious intercurrent medical illness * require emergency surgical intervention that would be inappropriately delayed by FLT-PET imaging
References
Publications (0)
Data not yet available